The hardest nut to crack is not the FDA, Dutta said
From a cardiovascular perspective, Ozempic has demonstrated protective effects in clinical trials
Its not about a quick fix
Obesity is a major risk factor for cardiovascular disease, the leading cause of death in people with common arthritides such as osteoarthritis (OA), gout, rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
(The most prescribed GLP-1RA was semaglutide, followed by dulaglutide and tirzepatide.) GLP-1-prescribed groups continued to show lower 1-year mortality, both without and with OSA
Of the 8 billion people in the world today, as many as 500 million have diabetes, and nearly 1 billion are obese